NAS:GHRS (Ireland)  
GH Research PLC logo

GH Research PLC

$ 11.62 -0.6 (-4.91%) 10:08 PM EST
P/E:
At Loss
P/B:
2.30
Market Cap:
$ 604.48M
Enterprise V:
$ 339.11M
Volume:
15.92K
Avg Vol (2M):
36.93K
Also Trade In:
Volume:
15.92K
Market Cap $:
604.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
36.93K
Enterprise Value $:
339.11M
PB Ratio:
2.30
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.99
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.96
9-Day RSI 42.46
14-Day RSI 43.97
6-1 Month Momentum % -14.98
12-1 Month Momentum % -29.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 86.02
Quick Ratio 86.02
Cash Ratio 85.74

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-12-06 Est.)

GHRS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GHRS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.226
Beta 0
Volatility % 72.67
14-Day RSI 43.97
14-Day ATR ($) 1.410833
20-Day SMA ($) 12.70675
12-1 Month Momentum % -29.51
52-Week Range ($) 8.72 - 30.43
Shares Outstanding (Mil) 52.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GH Research PLC Filings

Document Form Filing Date
No Filing Data

GH Research PLC Analysis

Share your research

Headlines

See More
No news.